Anesthesia PraCtice for Cesarean DElivery Snapshot Survey: ACCESS Study
Dear Colleagues,
From the ESAIC-Obstetric Anaesthesiology Subcommittee 4, we are planning to launch a new survey study to assess anesthesia practice during cesarean delivery.
This poll is designed to evaluate/confirm your interest to be Lead Investigator of your study center, to estimate the total number of cesarean delivery cases that may be surveyed in total, and to collect your contact details in order to send further information.
Our study goal is to recruit all consecutive cesarean deliveries in a 2 week (15-days) snapshot period in each participating center. This way we can gather information (limited number of outcomes) concerning anesthesia management of cesarean delivery.
The snapshot study is planned to open on September 1st 2023. This should give time for all centers to get the necessary approvals. Centers may specify their start date, once they have all the necessary approvals in place.
Note that the data introduced in this survey will used for identifying potential ACCESS study centers and will follow the GDPR.
Anxiolytic premedication in Europe
Dear colleagues!
This is an European survey concerning anxiolytic and sedative premedication and is part of a PhD thesis on the impact of midazolam on pain. Main objectives are to clarify:
- The actual standard of care concerning patient anxiety evaluation and management
- The role of midazolam in modern practice.
- The common perception of the impact of midazolam on patient outcomes.
If you work regularly in the operating theatre (anaesthetise at least 3 patients per month), we invite you to complete a short anonymous survey about your current practice concerning anxiolytic premedication.
We thank you in advance for your cooperation.
Caroline Dahlem, Carmen Oliveira , Cristina Granja, Luís Azevedo
Variation in ASA Scoring (Milestone-2)
Dear colleagues,
The society is supporting the MILESTONE-2 survey, an international collaboration of (HPB) surgeons and anesthesiologist in which we want to explore the reasons behind the large variations seen in the ASA classification in patients undergoing HPB surgery. To what extent is this actually related to patient factors?
A previous study of our group found large differences in ASA scores in HPB surgery between different countries (USA vs European). For pancreatic surgery: ASA III/IV in NSQIP 78%, in Germany 48%, in the Netherlands 23%, and in Sweden only 3%. Since ASA is also utilized for case mix adjustment it is vital that consensus is reached on the practicalities of this system.
